GSK vs IDR · P/E 13, $103.31B cap vs P/E 21, rev $25.2M
GlaxoSmithKline PLC ADR (GSK) versus Idaho Strategic Resources Inc (IDR) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Idaho Strategic Resources Inc (IDR) is a gold company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported IDR revenue for 2026-06-30 was $25.2M. Net income was $10.0M. Revenue was up 74.1% from 2026-03-31 to 2026-06-30. IDR currently screens at market cap $183.6M and trailing P/E 21.1.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. IDR currently screens at market cap $183.6M and trailing P/E 21.1.
Not investment advice. Open the GSK and IDR stock pages for the full models.
Not investment advice.